Home › Funds › Stonepine Capital Management, LLC › ALMS
Stonepine Capital Management, LLC position in ALMS
ALUMIS INC · Health Care
Stonepine Capital Management, LLC reported holding 85,000 shares of ALMS (ALUMIS INC) in its Q3 2026 13F filing — a position valued at US$628K, representing 0.48% of its reported portfolio and ranking #42 among its reported holdings. Stonepine Capital Management, LLC has disclosed ALMS holdings in 3 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Stonepine Capital Management, LLC's ALMS position evolved
Stonepine Capital Management, LLC first disclosed a stake in ALMS in Q2 2025 at 349,615 shares (US$1.0M). The position peaked in Q3 2025 at 300,000 shares, worth US$1.2M. Across 3 filings, Stonepine Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 85,000 shares valued at US$628K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 349.62K | $1.05M | New |
| Q3 2025 | 300.00K | $1.20M | Reduce |
| Q3 2026 | 85.00K | $628.15K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALMS and 13F data
ALMS (ALUMIS INC) is a Health Care company. 70 other funds we track also report a position in ALMS — the largest reported positions include AyurMaya Capital Management Company, LP (US$426.0M), Deep Track Capital, LP (US$178.6M), Samsara BioCapital, LLC (US$178.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALMS
- AyurMaya Capital Management Company, LP 15.14M sh · $426.03M · Q2 2026
- Deep Track Capital, LP 6.35M sh · $178.65M · Q2 2026
- Samsara BioCapital, LLC 6.35M sh · $178.55M · Q2 2026
- Foresite Capital Management V, LLC 5.90M sh · $165.94M · Q2 2026
- venBio Partners LLC 4.53M sh · $127.43M · Q2 2026
- Foresite Capital Management VI LLC 4.25M sh · $119.53M · Q2 2026
- Nextech Invest Ltd. 3.54M sh · $99.64M · Q2 2026
- Cormorant Asset Management, LP 3.29M sh · $92.46M · Q2 2026
- Saturn V Capital Management LP 2.92M sh · $82.04M · Q2 2026
- Octagon Capital Advisors LP 2.83M sh · $79.66M · Q2 2026
- MPM BioImpact LLC 2.02M sh · $56.82M · Q2 2026
- BAKER BROS. ADVISORS LP 2.01M sh · $56.63M · Q2 2026
More on Stonepine Capital Management, LLC
FAQ
How long has Stonepine Capital Management, LLC held ALMS?
Stonepine Capital Management, LLC has disclosed ALMS holdings in 3 of the last 6 reported quarters, going back to Q2 2025.
What is Stonepine Capital Management, LLC's current position in ALMS?
As of Q3 2026, Stonepine Capital Management, LLC holds 85.00K shares of ALMS (ALUMIS INC), valued at $628.15K, representing 0.48% of its reported portfolio and ranking #42.
Has Stonepine Capital Management, LLC been buying or selling ALMS?
In the latest 13F filing (Q3 2026), Stonepine Capital Management, LLC newly opened its position in ALMS. The position peaked in Q3 2025 at 300.00K shares.
Which other funds hold ALMS?
Other major institutional holders of ALMS include AyurMaya Capital Management Company, LP, Deep Track Capital, LP, Samsara BioCapital, LLC, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.